Zdrowie i gospodarka · 25/10/2018

FDA Releases Final Guidance on Testicular Toxicity Evaluation During Drug Development

The US Food and Drug Administration (FDA) has published a final guidance document to help pharmaceutical companies assess potential testicular toxicity in their drug development processes, building on nonclinical findings and clinical trial designs to minimize risks to human subjects.